Medscape
TOPLINE: An analysis of data from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database revealed differences in patterns of ocular events associated with oral and injectable formulations of semaglutide, with injectable formulations linked to a higher frequency of retinal complications. METHODOLOGY: The FDA has approved semaglutide as both a subcutaneous injection …
Read More
Oral, Injected Semaglutide May Pose Distinct Eye Risks
Qiana Mcnaught
10:20
TOPLINE: An analysis of data from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database revealed differences in patterns of ocular events associated with oral and injectable formulations of semaglutide, with injectable formulations linked to a higher frequency of retinal complications. METHODOLOGY: The FDA has approved semaglutide as both a subcutaneous injection
